• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染丙型肝炎病毒1a或1b基因型的北美患者中丙型肝炎病毒NS5A基因的突变

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.

作者信息

Hofgärtner W T, Polyak S J, Sullivan D G, Carithers R L, Gretch D R

机构信息

Department of Laboratory Medicine, University of Washington Medical Center, Seattle, USA.

出版信息

J Med Virol. 1997 Oct;53(2):118-26. doi: 10.1002/(sici)1096-9071(199710)53:2<118::aid-jmv3>3.0.co;2-c.

DOI:10.1002/(sici)1096-9071(199710)53:2<118::aid-jmv3>3.0.co;2-c
PMID:9334922
Abstract

Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [Enomoto et al. (1995): Journal of Clinical Investigation 96: 224-230; Enomoto et al. (1996): New England Journal of Medicine 334:77-81]. The present study examines amino acid sequences surrounding the putative Interferon Sensitivity Determining Region (ISDR) of the NS5A gene of HCV in 21 North American patients with genotype 1a or 1b infection receiving recombinant IFN therapy. The ISDR consensus or intermediate pattern was observed in 13 of 14 NS5A clones from North American patients infected with genotype 1b. However, we found no evidence of the consensus ISDR sequence in any NS5A clones isolated from 15 patients with genotype 1a infection. In select cases, gel shift analysis showed no significant changes in the clonal frequency of the putative ISDR domain of HCV genotype 1a or 1b infected patients who were either nonresponsive to IFN therapy, or relapsed following withdrawal of IFN therapy. These results suggest that a conserved ISDR domain is neither associated with, nor responsible for, IFN resistance in North American patients infected with HCV genotype 1a, and demonstrate a need for further investigation into the reported association between ISDR consensus sequences and IFN resistance in genotype 1b clones.

摘要

日本此前的研究描述了丙型肝炎病毒(HCV)基因组内一个保守序列与感染HCV 1b基因型患者对干扰素(IFN)治疗的耐药性之间的关联[榎本等人(1995年):《临床研究杂志》96:224 - 230;榎本等人(1996年):《新英格兰医学杂志》334:77 - 81]。本研究检测了21名接受重组IFN治疗的北美1a或1b基因型感染患者中,HCV NS5A基因假定的干扰素敏感性决定区域(ISDR)周围的氨基酸序列。在14个来自感染1b基因型的北美患者的NS5A克隆中,有13个观察到ISDR共有序列或中间模式。然而,我们在从15名1a基因型感染患者分离的任何NS5A克隆中均未发现共有ISDR序列的证据。在特定病例中,凝胶迁移分析显示,对IFN治疗无反应或在停止IFN治疗后复发的HCV 1a或1b基因型感染患者,其假定的ISDR结构域的克隆频率无显著变化。这些结果表明,在北美感染HCV 1a基因型的患者中,一个保守的ISDR结构域既不与IFN耐药性相关,也不是其原因,并表明需要进一步研究报道的1b基因型克隆中ISDR共有序列与IFN耐药性之间的关联。

相似文献

1
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.感染丙型肝炎病毒1a或1b基因型的北美患者中丙型肝炎病毒NS5A基因的突变
J Med Virol. 1997 Oct;53(2):118-26. doi: 10.1002/(sici)1096-9071(199710)53:2<118::aid-jmv3>3.0.co;2-c.
2
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.丙型肝炎病毒1b基因型的干扰素耐药性:与非结构5A基因准种突变的关系。
J Virol. 1998 Apr;72(4):2795-805. doi: 10.1128/JVI.72.4.2795-2805.1998.
3
Mutations in ISDR of NS5A gene influence interferon efficacy in Chinese patients with chronic hepatitis C virus genotype 1b infection.NS5A基因ISDR区域的突变影响中国慢性丙型肝炎病毒1b型感染患者的干扰素疗效。
J Gastroenterol Hepatol. 2007 Nov;22(11):1898-903. doi: 10.1111/j.1440-1746.2006.04566.x.
4
Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.日本丙型肝炎病毒 1a 基因型的流行情况以及 NS5A 区突变与白细胞介素 28B 单核苷酸多态性与聚乙二醇干扰素-α 2b 和利巴韦林联合治疗反应的相关性。
J Med Virol. 2012 Mar;84(3):438-44. doi: 10.1002/jmv.23207.
5
Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?对丙型肝炎病毒NS5A的PKRBD进行测序能否预测澳大利亚人群联合治疗的疗效?
J Gastroenterol Hepatol. 2004 May;19(5):551-7. doi: 10.1111/j.1440-1746.2003.03319.x.
6
Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.在诱导和联合抗病毒治疗期间对全长丙型肝炎病毒NS5A准种进行前瞻性特征分析。
J Virol. 2000 Oct;74(19):9028-38. doi: 10.1128/jvi.74.19.9028-9038.2000.
7
Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy.丙型肝炎病毒 1a、1b、3a、3b、6f 基因型核心和 NS5A 基因的突变与聚乙二醇干扰素和利巴韦林联合治疗应答的相关性。
J Viral Hepat. 2011 Apr;18(4):e117-25. doi: 10.1111/j.1365-2893.2010.01379.x. Epub 2010 Oct 19.
8
Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.慢性丙型肝炎 3a 型中两个 PKR 结合域的突变与病毒载量和干扰素反应的相关性。
J Med Virol. 2011 Oct;83(10):1727-32. doi: 10.1002/jmv.21959.
9
The NS5a gene of hepatitis C virus in patients treated with interferon-alpha.接受α干扰素治疗的丙型肝炎病毒患者的NS5a基因
J Med Virol. 2000 Apr;60(4):367-78.
10
[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin].[在使用或不使用利巴韦林进行干扰素治疗前对丙型肝炎病毒NS5A区域的ISDR和V3结构域进行突变分析]
Pathol Biol (Paris). 2004 Nov;52(9):505-10. doi: 10.1016/j.patbio.2004.07.011.

引用本文的文献

1
Hepatitis C virus nonstructural protein 5A inhibits thapsigargin-induced apoptosis.丙型肝炎病毒非结构蛋白5A抑制毒胡萝卜素诱导的细胞凋亡。
PLoS One. 2014 Nov 19;9(11):e113499. doi: 10.1371/journal.pone.0113499. eCollection 2014.
2
Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.丙型肝炎病毒异质性对干扰素敏感性的影响:综述
World J Gastroenterol. 2014 Jun 28;20(24):7555-69. doi: 10.3748/wjg.v20.i24.7555.
3
Hepatitis C genotype 6: A concise review and response-guided therapy proposal.丙型肝炎病毒6型:简要综述及应答导向治疗建议
World J Hepatol. 2013 Sep 27;5(9):496-504. doi: 10.4254/wjh.v5.i9.496.
4
Impact of host and virus genome variability on HCV replication and response to interferon.宿主和病毒基因组变异性对 HCV 复制和干扰素应答的影响。
Curr Opin Virol. 2013 Oct;3(5):501-7. doi: 10.1016/j.coviro.2013.06.005. Epub 2013 Jul 6.
5
Mutations around interferon sensitivity-determining region: a pilot resistance report of hepatitis C virus 1b in a Hong Kong population.干扰素敏感性决定区周围的突变:香港人群中丙型肝炎病毒 1b 的耐药性初步报告。
World J Gastroenterol. 2011 Dec 28;17(48):5317-23. doi: 10.3748/wjg.v17.i48.5317.
6
Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy.分析与聚乙二醇干扰素和利巴韦林治疗反应相关的基因型 2b 丙型肝炎病毒的完整开放阅读框。
PLoS One. 2011;6(9):e24514. doi: 10.1371/journal.pone.0024514. Epub 2011 Sep 15.
7
Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.针对感染 HCV 3a 的巴基斯坦患者的联合治疗反应及 NS5A 蛋白的作用。
Virol J. 2011 May 25;8:258. doi: 10.1186/1743-422X-8-258.
8
Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection.干扰素敏感决定区突变与聚乙二醇干扰素 α-2b 联合利巴韦林治疗慢性丙型肝炎 1b 感染患者的病毒学应答
J Gastroenterol. 2010 Jun;45(6):656-65. doi: 10.1007/s00535-009-0195-7. Epub 2010 Jan 30.
9
Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.影响聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎疗效的病毒因素
J Gastroenterol. 2009;44(10):1009-15. doi: 10.1007/s00535-009-0126-7.
10
Evidence of recombination in intrapatient populations of hepatitis C virus.丙型肝炎病毒患者体内种群中重组的证据。
PLoS One. 2008 Sep 18;3(9):e3239. doi: 10.1371/journal.pone.0003239.